把三张表、经营指标、SEC / 巨潮 / 港交所原始财报、业绩材料和电话会放到同一条可核验时间线上。 披露事实、结构化补位值与派生指标分开标注，缺失逐字稿不会用摘要或模型生成内容补齐。
单季、累计、年度和资产负债表时点分开保存；每个数值都保留单位、申报日、表单、XBRL 概念或原始中文字段。
美股链接 SEC 法定申报和发行人 IR，A 股链接巨潮原始 PDF，港股链接港交所披露易原始年报与中报。分部、订单、产能和客户集中度只在有可核验披露时展示。
官方电话会入口与已授权逐字稿分开。没有合法取得的全文时只显示材料可用性，不生成或拼接虚假的逐字稿。
三张表会执行资产负债、毛利润、税前利润等勾稽检查；超出容差的记录保留原值并标记警告， 不会为了让公式“对上”而修改公司披露。
| 2026-04-04 |
| 3/3 |
| $839.24M |
| $7.16M |
| — |
| 21.0% |
| 2.6% |
| 114 |
| 尚无授权文本 |
| NVST Envista Holdings Corp | 2026-04-03 | 3/3 | $705.5M | $38.7M | -$15.8M | 55.3% | 8.9% | 85 | 尚无授权文本 |
| VSTS Vestis Corp | 2026-04-03 | 3/3 | $659.44M | $2.6M | — | — | 4.1% | 51 | 尚无授权文本 |
| ANVS Annovis Bio, Inc. | 2026-03-31 | 3/3 | $0 | -$17.61M | — | — | — | 99 | 尚无授权文本 |
| CNVS Cineverse Corp. | 2026-03-31 | 3/3 | $65.73M | -$8.66M | — | — | -23.1% | 134 | 尚无授权文本 |
| CRVS Corvus Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$13.69M | -$10.47M | — | — | 87 | 尚无授权文本 |
| CVS CVS HEALTH Corp | 2026-03-31 | 3/3 | $100.43B | $2.94B | $3.4B | 44.8% | 4.7% | 128 | 尚无授权文本 |
| CVSA Covista Inc. | 2026-03-31 | 3/3 | $487.03M | $41.64M | $295.58M | 56.7% | 18.8% | 98 | 尚无授权文本 |
| MVST Microvast Holdings, Inc. | 2026-03-31 | 3/3 | $60.61M | $48.21M | -$25.65M | 31.6% | -13.1% | 101 | 尚无授权文本 |
| RVSB RIVERVIEW BANCORP INC | 2026-03-31 | 3/3 | — | -$8.04M | — | — | — | 86 | 尚无授权文本 |
| UAVS AgEagle Aerial Systems Inc. | 2026-03-31 | 3/3 | — | $1.42M | -$2.72M | — | — | 121 | 尚无授权文本 |
| VIVS VivoSim Labs, INC. | 2026-03-31 | 3/3 | $131,000 | -$13.84M | -$10.83M | 100.0% | -8768.7% | 72 | 尚无授权文本 |
| VS Versus Systems Inc. | 2026-03-31 | 3/3 | $17,300 | -$683,200 | — | 100.0% | -4732.3% | 102 | 尚无授权文本 |
| VSAT VIASAT INC | 2026-03-31 | 3/3 | $4.64B | -$34.09M | — | — | 2.3% | 98 | 尚无授权文本 |
| VSEC VSE CORP | 2026-03-31 | 3/3 | $324.58M | $29.06M | -$68.72M | — | 10.1% | 111 | 尚无授权文本 |
| VSECU VSE CORP | 2026-03-31 | 3/3 | $324.58M | $29.06M | -$68.72M | — | 10.1% | 111 | 尚无授权文本 |
| VSEE VSEE HEALTH, INC. | 2026-03-31 | 3/3 | $3.16M | -$2.6M | -$2.48M | 37.9% | -94.1% | 104 | 尚无授权文本 |
| VSNT Versant Media Group, Inc. | 2026-03-31 | 3/3 | $1.69B | $286M | $558M | — | 26.2% | 9 | 尚无授权文本 |
| VST Vistra Corp. | 2026-03-31 | 3/3 | $5B | $1.03B | $316M | — | 30.0% | 130 | 尚无授权文本 |
| VSTM Verastem, Inc. | 2026-03-31 | 3/3 | $18.67M | -$36.59M | — | — | -240.5% | 95 | 尚无授权文本 |
| BVS Bioventus Inc. | 2026-03-28 | 3/3 | $132.09M | $3.11M | $8.36M | 68.7% | 6.4% | 91 | 尚无授权文本 |
| KYIV Kyivstar Group Ltd. | 2025-12-31 | 2/3 | — | $124M | — | — | — | 22 | 尚无授权文本 |
| NVS NOVARTIS AG | 2025-12-31 | 2/3 | — | $13.97B | — | — | — | 92 | 尚无授权文本 |
| PHVS Pharvaris N.V. | 2025-12-31 | 2/3 | — | -$175.7M | — | — | — | 76 | 尚无授权文本 |
| RVSN Rail Vision Ltd. | 2025-12-31 | 3/3 | $1.49M | -$11.1M | -$9.25M | 37.1% | -789.2% | 119 | 尚无授权文本 |
| VSA VisionSys AI Inc | 2025-12-31 | 3/3 | $1.04M | $245.8M | — | 22.1% | -3836.9% | 93 | 尚无授权文本 |
| VSME VS MEDIA Holdings Ltd | 2025-12-31 | 3/3 | $7.52M | -$8.61M | -$3.53M | 23.7% | -85.4% | 32 | 尚无授权文本 |
| PAVS Paranovus Entertainment Technology Ltd. | 2025-09-30 | 3/3 | $12.41M | -$680,952 | — | 20.0% | -5.1% | 79 | 尚无授权文本 |